 |
Articles: Regulatory Issues |
Prior Articles
Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
Cell Therapeutics, 06/25/09
Free full text
Regulatory update for REZONIC (casopitant mesylate)
GlaxoSmithKline, 06/24/09
Free full text
Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
Merck & Co., 06/23/09
Free full text
Biovail Announces Closing of Acquisition of Worldwide Rights to Tetrabenazine
BioVail Corporation, 06/23/09
Free full text
The Ups and Downs of the FDA Budget
BioPharm, 06/22/09
Free full text
Stiffer Enforcement at the FDA
BioPharm, 06/22/09
Free full text
Court Grants Teva Summary Judgment Of Non-Infringement On Eloxatin
Teva Pharmaceutical Industries, 06/19/09
Free full text
Oscient Pharmaceuticals Lays Off 180 Reps
PharmExec, 06/18/09 Fda extends review of arzerra (ofatumumab)
Genmab, 06/18/09
Free full text
FDA extends review of Arzerra (ofatumumab)
GlaxoSmithKline, 06/17/09
Free full text
Genzyme Temporarily Interrupts Production at Allston Plant
Genzyme, 06/17/09
Free full text
A systematic review of interventions to improve recall of medical advice in healthcare consultations
Journal of the Royal Society of Medicine, 06/17/09 Insulin detemir alert issued by FDA
American Pharmacists Association, 06/15/09
Free full text
Taro Announces Preliminary Court Approval of Settlement in Securities Lawsuit
Taro Pharmaceuticals USA, 06/12/09
Free full text
FDA Classifies Previously Announced Medtronic Physician Advisory on Small Subset of Kappa and Sigma Pacemakers as Class I Recall
Medtronic, 06/11/09
Free full text
Capital increase in genmab as a result of employee warrant exercise
Genmab, 06/11/09
Free full text
Corporations Need to Tackle Global Corruption as Strategic CSR Effort
Merck & Co., 06/10/09
Free full text
Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD, an Investigational Treatment for Mixed Dyslipidemia
Abbott, 06/05/09 AstraZeneca and Abbott submit New Drug Application to the FDA for CERTRIAD, an investigational treatment for mixed dyslipidemia
AstraZeneca, 06/05/09
Free full text
Adolor Corporation Announces Staff Reductions and Restructuring
Adolor Corporation, 06/04/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
